The DUO trial: dose modifications on response to duvelisib in patients with SLL/CLL
Paolo Ghia • 20 Sep 2019
Duvelisib after progression on ofatumumab in R/R CLL: DUO crossover extension study
DUO results: duvelisib or ofatumumab monotherapy for R/R CLL?
Stephan Stilgenbauer • 25 Oct 2018